logo

METABOLIC KINETICS OF BRAIN MUSCARINIC CHOLINERGIC RECEPTORS IN NORMAL AND HYPOTHYROID MICE

METABOLIC KINETICS OF BRAIN MUSCARINIC CHOLINERGIC RECEPTORS IN NORMAL AND HYPOTHYROID MICE

Hu Ya'er
Yi Ningyu
He Luming
Xia Zongqin
Nuclear Science and TechniquesVol.4, No.4pp.222-229Published in print 01 Nov 1993
22700

A technique for studying in vivo the production rate and turnover rate constant of mouse brain M-receptors was established. A single injection of 25 mg / kg of Benzilylcholine Mustard to living mice resulted in 90 % irreversible block of brain M-receptors. The time course of the receptor density was then monitored by 3H-QNB binding assay and the production rate and turnover rate constant were calculated from the time course curve with a computer program. It was found that in normal mice the turnover rate constant was about 0.035 h-1 (half-life was about 20 h) and the production rate was 30-42 fmol / (h · mg protein). Parallel experiments revealed a significant slow down of the turnover of brain M-receptors in hypothyroid mice (turnover rate constant was 0.0257±0.0012 h-1 in hypothyroid vs. 0.0356 ± 0.0021 h-1 in normal) while the production rate was not changed significantly. The results suggest that thyroid hormones have a regulatory action on the turnover of brain M-receptors and the elevation of brain M-receptor density together with slow down of the turnover of brain M-receptors is probably one of the important mechanisms relevant to the brain dysfunction in hypothyroidism.

HypothyroidismMuscarinic cholinergic receptorBenzilylcholine mustard (BCM)Metabolic kinetics of M-receptorBrain M-receptor
REFERENCES
1 DeGroot L J, Larsen P R, Refetoff S et al. The thyroid and its disease. 5th ed. New York: John Wiley and Sons, 1984; 574
2 Megaugh J L. Ann Rev Neurosci, 1989; 12: 255
3 Pepeu G. Pharmacol Res Commun, 1988; 20: 91
4 Berger M, Fleckensten P, Riemann D et al. In: Bunney W E, Hippius H, Laakman G et al. eds. Neuropsycho-pharmacology. Berlin: Springer Verlag, 1990; 208
5 Gharma V K, Banerjee S P. J Biochem, 1977; 252: 7444
6 Patel A J, Smith R M, Kingsburg A E et al. Brain Res. 1980; 198: 389
7 Kastrup J, Christensen N J. Scand J Clin Lab Invest, 1984; 44: 33
8 Gill E W, Rang H G. Mol Pharmacol, 1966; 2: 284
9 Yamamura H I, Snyder S H. Proc Natl Acad Sci USA, 1974; 71: 1725
10 Schlief R F, Wensink P C. Practical methods in molecular biology. New York: Springer-Verlag, 1981; 75
11 Hunter D D, Nathanson N M. J Neuroscience, 1986; 6: 3739
12 Xia Zongqin. Nucl Sci Techniq, 1990; 1: 161
13 Reed B C, Lane D M. Proc Natl Acad Sci, 1980; 77: 285
14 Diem K, Lentner C eds. Scientific tables, 7th ed. Basel: Ciba-Geigy, 1971; 178
15 Mahan L C, Mckeman R M, Insel P A et al. Ann Rev Pharmacol Toxicol, 1987; 27: 215
16 Siegek H, Triggle D J. Life Sciences, 1982; 30: 1645
17 Christophe J, Neef P D, Robberecht P R. Br J Pharmacol, 1986; 88: 63
18 Rang H P. Ann New York Acad Sci, 1967; 144: 756
19 Waisberg M, Shainberg A. Biochem Pharmacol, 1992; 41: 2327
20 Muller W E. Acta Psychiatr Scand. 1991; Suppl. 366: 5
21 Spiegel R. Acta Psychiatr Scand, 1991; Suppl. 366: 66